NIH-funded research R01 grant

Understanding cell death in a common eye disease

Official title: Modulating Ferroptosis in Fuchs Endothelial Corneal Dystrophy

Funded at University of Iowa · NIH-11073630 · Data updated 2026-11-12

This study is looking into Fuchs endothelial corneal dystrophy, a condition that affects many people over 40 and can lead to needing a corneal transplant, to understand how certain cell damage happens and find new ways to help prevent or treat the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Iowa
NIH-funded
Lab location1 site (Iowa City, United States)
Project startMarch 1, 2025
Project endFebruary 28, 2030
Funding year2025
Award (this year)$588,731
NIH project number1R01EY037135-01
Project IDNIH-11073630 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals over 40 years old who have been diagnosed with Fuchs endothelial corneal dystrophy.

Less likely to help

Patients with other forms of corneal dystrophy or those who do not have FECD may not benefit from this research.

What this research studies

This research investigates Fuchs endothelial corneal dystrophy (FECD), a condition affecting millions of Americans over 40 that leads to corneal transplant surgery. The study focuses on a specific type of cell death called ferroptosis, which is driven by oxidative stress and iron accumulation in corneal cells. By examining the mechanisms behind this cell death, particularly in relation to genetic factors and environmental triggers like UV light, the research aims to identify potential therapeutic targets to prevent disease progression. Patients may benefit from insights that could lead to new treatments or preventive measures for FECD.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that prevent or slow the progression of Fuchs endothelial corneal dystrophy, reducing the need for corneal transplants.

How similar studies have gone: While the specific approach of targeting ferroptosis in FECD is novel, similar research has shown promise in understanding cell death mechanisms in other diseases.

Where this research is happening

  • University of Iowa
    Iowa City, United States
    Active

Researchers

  • Principal investigator: Greiner, Mark Aaron — University of Iowa
  • Study coordinator: Greiner, Mark Aaron

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.